Michael J. Janusz

2.1k total citations
44 papers, 1.6k citations indexed

About

Michael J. Janusz is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Michael J. Janusz has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Michael J. Janusz's work include Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (12 papers) and Synthesis and biological activity (8 papers). Michael J. Janusz is often cited by papers focused on Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (12 papers) and Synthesis and biological activity (8 papers). Michael J. Janusz collaborates with scholars based in United States, Poland and Canada. Michael J. Janusz's co-authors include Lily C. Hsieh, Yetunde O. Taiwo, Kimberly K. Brown, S.A. Heitmeyer, Biswanath De, J K Czop, Michael G. Natchus, K. Frank Austen, Neil G. Almstead and Niall S. Doherty and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Michael J. Janusz

44 papers receiving 1.5k citations

Peers

Countries citing papers authored by Michael J. Janusz

Since Specialization

Citations

This map shows the geographic impact of Michael J. Janusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Janusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Janusz more than expected).

Fields of papers citing papers by Michael J. Janusz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Janusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Janusz. The network helps show where Michael J. Janusz may publish in the future.

Co-authorship network of co-authors of Michael J. Janusz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Janusz. A scholar is included among the top collaborators of Michael J. Janusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Janusz. Michael J. Janusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis 2008 ·Journal of Inflammation ·Kimberly K. Brown, S.A. Heitmeyer, (unknown), Lily C. Hsieh, Maria Buchalova, Yetunde O. Taiwo, Michael J. Janusz	57
2	Development of N-4,6-pyrimidine-N-alkyl-N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer A. Maier, Todd A. Brugel, M. Sabat, Adam Gołȩbiowski, Matthew J. Laufersweiler, John C. VanRens, Corey R. Hopkins, Biswanath De, Lily C. Hsieh, Kimberly K. Brown, (unknown), Michael J. Janusz	12
3	The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Matthew J. Laufersweiler, Todd A. Brugel, Jennifer Maier, Adam Gołȩbiowski, Biswanath De, (unknown), Lily C. Hsieh, Richard L. Walter, Marlene Mekel, A.G. Evdokimov, Michael J. Janusz	57
4	The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Michael P. Clark, Todd A. Brugel, Jennifer Maier, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), Adam Gołȩbiowski, Biswanath De, Lily C. Hsieh, Richard L. Walter, Marlene Mekel, Michael J. Janusz	11
5	Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis 2006 ·Inflammation Research ·Michael J. Janusz, (unknown), Kimberly K. Brown, Lily C. Hsieh, S.A. Heitmeyer, Yetunde O. Taiwo, Michael G. Natchus, (unknown), Neil G. Almstead, Bing‐ling Peng, Timothy R. Baker, (unknown)	12
6	Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd A. Brugel, Jennifer A. Maier, Michael P. Clark, M. Sabat, Adam Gołȩbiowski, Roger G. Bookland, Matthew J. Laufersweiler, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, Marlene Mekel, Michael J. Janusz	15
7	The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck) 2006 ·Bioorganic & Medicinal Chemistry Letters ·M. Sabat, John C. VanRens, Todd A. Brugel, Jennifer Maier, Matthew J. Laufersweiler, Adam Gołȩbiowski, Biswanath De, (unknown), Lily C. Hsieh, (unknown), (unknown), Eric G. Suchanek, Michael J. Janusz	18
8	The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones 2004 ·Bioorganic & Medicinal Chemistry Letters ·Matthew J. Laufersweiler, Todd A. Brugel, Michael P. Clark, Adam Gołȩbiowski, Roger G. Bookland, (unknown), M. Sabat, (unknown), John C. VanRens, Biswanath De, Lily C. Hsieh, S.A. Heitmeyer, (unknown), Kimberly K. Brown, Marlene Mekel, Richard L. Walter, Michael J. Janusz	17
9	Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration 2004 ·Osteoarthritis and Cartilage ·Michael J. Janusz, Christopher B. Little, Lindsay E. King, (unknown), Kimberly K. Brown, S.A. Heitmeyer, Bruce Caterson, A. Robin Poole, Yetunde O. Taiwo	45
10	Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor 2002 ·Osteoarthritis and Cartilage ·Michael J. Janusz, A.M. Bendele, Kimberly K. Brown, Yetunde O. Taiwo, Lily C. Hsieh, S.A. Heitmeyer	186
11	The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Matthew J. Laufersweiler, John C. VanRens, Michael G. Natchus, Roger G. Bookland, Neil G. Almstead, Stanisław Pikul, Biswanath De, Lily C. Hsieh, Michael J. Janusz, (unknown), Sean Peng, (unknown), Tomáš Hudlický, (unknown)	17
12	Design, Synthesis, and Biological Evaluation of Matrix Metalloproteinase Inhibitors Derived from a Modified Proline Scaffold 1999 ·Journal of Medicinal Chemistry ·(unknown), Biswanath De, Neil G. Almstead, Stanisław Pikul, Martin E. Dowty, (unknown), C. Michelle Dunaway, Fei Gu, Lily C. Hsieh, Michael J. Janusz, Yetunde O. Taiwo, Michael G. Natchus, Tomáš Hudlický, Martin Mandel	45
13	Cartilage proteoglycan degradation by a mouse transformed macrophage cell line is mediated by macrophage metalloelastase 1999 ·Inflammation Research ·Michael J. Janusz, Michael F. Hare, (unknown), Jan Potempa, Walker T. McGraw, Robert N. Pike, James Travis, Steven D. Shapiro	14
14	Pharmacological evaluation of selected, orally active, peptidyl inhibitors of human neutrophil elastase. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Michael J. Janusz, (unknown), (unknown), (unknown), (unknown), J. C. F. Poole, Thomas N. Thompson, Daigen Xu, (unknown), Joseph P. Burkhart	2
15	Inhibition of Human Neutrophil Elastase. 3. An Orally Active Enol Acetate Prodrug 1995 ·Journal of Medicinal Chemistry ·Joseph P. Burkhart, Jack R. Koehl, Shujaath Mehdi, (unknown), Michael J. Janusz, Edward W. Huber, Michael R. Angelastro, Shyam Sunder, William A. Metz	17
16	Inhibition of human neutrophil elastase and cathepsin G by a diphenyl disulfonic acid copolymer 1994 ·International Journal of Immunopharmacology ·Michael J. Janusz, (unknown)	8
17	Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastase. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), Michael R. Angelastro, Joseph P. Burkhart, Jack R. Koehl, (unknown), Mehdi Stiti, (unknown), Michael J. Janusz	8
18	Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation 1993 ·The Journal of Immunology ·Michael J. Janusz, Michael F. Hare	28
19	Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G 1991 ·The Journal of Immunology ·Michael J. Janusz, Niall S. Doherty	66
20	Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors. 1986 ·The Journal of Immunology ·Michael J. Janusz, K. Frank Austen, J K Czop	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact